Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Vasopressin. Always confirm against the full prescribing information.
64 interactions
Botulinum toxin type A
Botulinum toxin type A may increase the hypertensive activities of Vasopressin.
Level 1 evidence
Botulinum toxin type B
Botulinum toxin type B may increase the hypertensive activities of Vasopressin.
Level 1 evidence
Carbamazepine
The risk or severity of water intoxication can be increased when Carbamazepine is combined with Vasopressin.
Level 1 evidence
Carbidopa
Vasopressin may increase the hypertensive activities of Carbidopa.
Level 1 evidence
Chloroprocaine
The risk or severity of adverse effects can be increased when Vasopressin is combined with Chloroprocaine.
Level 1 evidence
Clozapine
Clozapine may decrease the fluid retaining and vasopressor activities of Vasopressin.
Level 1 evidence
Demeclocycline
Demeclocycline may decrease the fluid retaining and vasopressor activities of Vasopressin.
Level 1 evidence
Dobutamine
Vasopressin may increase the hypertensive activities of Dobutamine.
Level 1 evidence
Dopamine
Vasopressin may increase the hypertensive activities of Dopamine.
Level 1 evidence
Droxidopa
Vasopressin may increase the hypertensive activities of Droxidopa.
Level 1 evidence
Epinephrine
Vasopressin may increase the hypertensive activities of Epinephrine.
Level 1 evidence
Foscarnet
Foscarnet may decrease the fluid retaining and vasopressor activities of Vasopressin.
Vasopressin has 64 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Vasopressin has 0 major, 26 moderate, and 38 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Vasopressin. Always confirm against the full prescribing information.